XBI

Recent Articles

Go Long Biotech Stocks for a Donald Trump Win (LABU)

Recently Trump has been gaining in the polls. A Trump win could cause a rally in the biotech sector. Buy calls into the elections. More 

SPDR S&P Biotech (ETF) (XBI): The Bears Got Nothin’ on Biotech Stocks

Buyers are dominating in biotech stocks. Embrace the relative strength with this XBI play. High-probability profits await. More 

Biotech SPDR (XBI): Opportunity Lurks Amid the Biotech Swoon

The biotech stock swoon is a blip on the radar, nothing more. Fade the fear by selling juiced up XBI put options. More 

The 10 Best ETFs on the Planet

The best ETFs on the planet will outperform because of powerful generational megatrends, or just because they're built to withstand anything. More 

SPDR S&P Biotech (ETF) (XBI): Embrace the Biotech Bulls’ Return

Strength is returning anew to biotech stocks. Embrace the sector with a play on XBI to capitalize on further gains. More 

Gilead Sciences, Inc.: A Breakdown Looms for GILD Stock

Gilead Sciences is sitting out the biotech stock rally. In fact, an ugly breakdown looms for the ailing drug stock. Buy GILD stock puts. More 

3 High-Growth ETFs That Are Just Waiting to Explode

Investors have lost their nerve for now, but these growth plays are going to be prime buying grounds the second Wall Street perks up. More